Spikevax bivalent Original / Omicron 0.1 mg/mL dispersion for injection
Spikevax bivalent Original / Omicron is indicated for active immunisation to prevent COVID 19 disease caused by SARS- CoV-2 in individuals 18 years of age and older.
Patient Information Leaflet
Summary of Product Characteristics
Spikevax (previously COVID-19 Vaccine Moderna)
Spikevax 0,20 mg/ml formulation
Interim authorisation is granted for the Spikevax emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 years of age and older.
Patient Information Leaflet
Summary of Product Characteristics
Spikevax (previously COVID-19 Vaccine Moderna)
Spikevax 0,10 mg/ml formulation
Interim authorisation is granted for the Spikevax emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 months of age and older.
Patient Information Leaflet
Summary of Product Characteristics
Tools
Temperature Excursion Tool
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.
Contact Moderna
8am-5pm SST – Mon - Fri
APACmedinfo@modernatx.com